Lack of association between schizophrenia and the apolipoprotein E ε4 allele

European Archives of Psychiatry and Clinical Neuroscience

Volumn 246, Issue 4, 1996, Pages 182-184

  Jonsson E ^a   Lannfelt, L ^b   Engvall, B ^b   Sedvall, G ^a  

^a KAROLINSKA INSTITUTE   (Sweden)

^b KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

Author keywords

Alzheimer's disease; Apolipoprotein E; Association study; Psychiatric genetics; Schizophrenia

Indexed keywords

APOLIPOPROTEIN A4;

ADULT; AGED; ALLELE; ARTICLE; CONTROLLED STUDY; FEMALE; GENE FREQUENCY; GENOTYPE; HUMAN; HUMAN CELL; MAJOR CLINICAL STUDY; MALE; MENTAL DISEASE; NEUROPATHOLOGY; PRIORITY JOURNAL; SCHIZOPHRENIA;

EID: 0030009177     PISSN: 09401334     EISSN: None     Source Type: Journal    
DOI: 10.1007/BF02188951     Document Type: Article

References (34)

1. Aksenova MV, Burbaeva GS, Kandror KV, Kapkov DV, Stepanov AS (1991) The decreased level of casein kinase 2 in brain cortex of schizophrenic and Alzheimer's disease patients. FEBS Lett 279:55-57
2. American Psychiatric Association (1987) Diagnostic and statistical manual of mental disorders (DSM-III-R); 3rd edn; revised. American Psychiatric Press. Washington DC
3. Amouyel P, Vidal O, Launay JM, Laplanche JL (1994) The apolipoprotein E alleles as major susceptibility factors for Creutzfeldt-Jakob disease. Lancet 344:1315-1318
4. Arnold SE, Franz BR, Trojanowski JQ (1994) Elderly patients with schizophrenia exhibit infrequent neurodegenerative lesions. Neurobiol Aging 15:299-303
5. Boyles JK, Pitas RE, Wilson E, Mahley RW, Taylor JM (1985) Apolipoprotein E association with astrocytic glia of the central nervous system and with non-myelinating glia of the peripheral nervous system. J Clin Invest 82:1501-1513
6. Casanova MF, Carosella NW, Gold JM, Kleinman JE, Weinberger DR, Powers RE (1993) A topographical study of senile plaques and neurofibrillary tangles in the hippocampi of patients with Alzheimer's disease and cognitively impaired patients with schizophrenia. Psychiatry Res 49:41-62
7. Corder EH, Saunders AM, Strittmatter WJ, Schmechel DE, Gaskell PC, Small GW, Roses AD, Haines JL, Pericak-Vance MA (1993) Gene dose of apolipoprotein E type 4 allele and the risk of Alzheimer's disease in late onset families. Science 261: 921-923
8. Davidson M, Haroutunian V (1995) Cognitive impairment in geriatric schizophrenic patients. Clinical and postmortem characterization. In: Bloom FE, Kupfer DJ (eds) Psychopharmacology: the fourth generation of progress. Raven Press, New York, pp 1447-1459
9. El-Mallakh RS, Kirch DG, Shelton R, Fan KJ, Pezeshkpour G, Kanhouwa S, Wyatt RJ, Kleinman JE (1991) The nucleus basalis of Meynert, senile plaques, and intellectual impairment in schizophrenia. J Neuropsychiatry Clin Neurosci 3:383-386
10. Gabriel SM, Bierer LM, Davidson M, Purohit DP, Perl DP, Haroutunian V (1994) Galanin-like immunoreactivity is increased in the postmortem cerebral cortex from patients with Alzheimer's disease. J Neurochem 62:1516-1523
11. Geijer T, Jönsson E, Neiman J (1995) Comment to "Dopamine D2 receptor gene polymorphisms in Scandinavian chronic alcoholics: a reappraisal". Eur Arch Psychiatry Clin Neurosci 245: 53-54
12. Geijer T, Neiman J, Rydberg U, Gyllander A, Jönsson E, Sedvall G, Valverius P, Terenius L (1994) Dopamine D2 receptor gene polymorphisms in Scandinavian chronic alcoholics. Eur Arch Psychiatry Clin Neurosci 244:26-32
13. Goldsmith SK, Joyce JN (1995) Alterations in hippocampal mossy fiber pathway in schizophrenia and Alzheimer's disease. Biol Psychiatry 37:122-126
14. Haroutunian V, Davidson M, Kanof PD, Perl DP, Powchik P, Losonczy M, McCrystal J, Purohit DP, Bierer LM, Davis KL (1994) Cortical cholinergic markers in schizophrenia. Schizophr Res 12:137-144
15. Harrison PJ (1995) On the neuropathology of schizophrenia and its dementia: neurodevelopmental, neurodegenerative, or both? Neurodegeneration 4:1-12
16. Heaton R, Paulsen JS, McAdams LA, Kuck J, Zisook S, Braff D, Harris J, Jeste DV (1994) Neuropsychological deficits in schizophrenics. Relationship to age, chronicity, and dementia. Arch Gen Psychiatry 51:469-476
17. Johnson G, Brane D, Block W, Kammen DP van, Gurklis J, Peters JL, Wyatt RJ, Kirck DG, Ghanbari HA, Merril CR (1992) Cerebrospinal fluid protein variations in common to Alzheimer's disease and schizophrenia. Appl Theor Electrophor 3: 47-53
18. Joober R, Rouleau G, Fon E, Lal S, Palmour R, Bloom D, Labelle A, Benkelfat C (1995) Apolipoprotein allelic variation in schizophrenia. Psychiatr Genet 5:S56
19. Jönsson E, Forsell C, Lanntelt L, Sedvall G (1995) Schizophrenia and APP gene mutations. Biol Psychiatry 37:135-136
20. Jönsson E, Lannfelt L, Sokoloff P, Schwartz J-C, Sedvall G (1993) Lack of association between schizophrenia and alleles in the dopamine D3 receptor gene. Acta Psychiatr Scand 87:345-349
21. Kendler KS, Diehl SR (1993) The genetics of schizophrenia: a current, genetic-epidemiologic perspective. Schizophr Bull 19:261-285
22. Kendler KS, Neale MC, Walsh D (1995) Evaluating the spectrum concept of schizophrenia in the Roscommon family study. Am J Psychiatry 152:749-754
23. Kounnas MZ, Moir RD, Rebeck GW, Bush AL, Argraves WS, Tanzi RE, Hyman BT, Strickland DK (1995) LDL receptor-related protein, a multifunctional apoE receptor, binds secreted β-amyloid precursor protein and mediates its degradation. Cell 82:331-340
24. Kraepelin E (1919) Dementia praecox and paraphrenia (Facsimile edn.). Krieger, Huntington, NY
25. Lannfelt L, Lilius L, Nastase M, Viitanen M, Fratiglioni L, Eggertsen G, Berglund L, Angelin B, Linder J, Winblad B, Basun H (1994) Lack of association between apolipoprotein E allele ∈4 and sporadic Alzheimer's disease. Neurosci Lett 169:175-178
26. Liu L, Forsell C, Lilius L, Axelman K, Corder EH, Lannfelt L (1996) Allelic association but only weak evidence for linkage to the apolipoprotein E locus in late-onset Swedish Alzheimer families. Am J Med Genet (in press)
27. Mant R, Asherson P, Gill M, McGuffin P, Owen M (1992) Schizophrenia scepticism. Nature Genet 2:12
28. Poirer J, Davignon J, Bouthillier D, Kogan S, Bertrand P, Gauthier S (1993) Apolipoprotein E polymorphism and Alzheimer's disease. Lancet 342:697-699
29. Prohovnik I, Dwork AJ, Kaufman MA, Willson N (1993) Alzheimer-type neuropathology in elderly schizophrenia patients. Schizophr Bull 19:805-816
30. Purohit DP, Davidson M, Perl DP, Powchik P, Haroutunian VH, Bierer LM, McCrystal J, Losonczy M, Davis KL (1993) Severe cognitive impairment in elderly schizophrenic patients: a clinicopathological study. Biol Psychiatry 33:255-260
31. Sarter M (1994) Neuronal mechanisms of the attentional dysfunctions in senile dementia and schizophrenia: to sides of the same coin? Psychopharmacology 114:539-550
32. Saunders AM, Strittmatter, WJ, Schmechel D, St.George-Hyslop PH, Pericak-Vance MA, Joo SH, Rosi BL, Gusella JF, Crapper-MacLachlan DR, Albert MJ, Hulette C, Grain B, Goldgaber D, Roses AD (1993) Association of apolipoprotein E allele Iisin4 with late-onset familial and sporadic Alzheimer's disease. Neurology 43:1467-1472
33. Shinitzky M, Deckmann M, Kessler A, Sirota P, Rabbs A, Elizur A (1991) Platelet autoantibodies in dementia and schizophrenia. Possible implication for mental disorders. Ann N Y Acad Sci 1621:205-217
34. Strittmatter WJ, Saunders AM, Schmechel D, Pericak-Vance M, Enghild J, Salvesen OS, Roses AD (1993) Apolipoprotein E: high avidity binding to β-amyloid and increased frequency of type 4 allele in late-onset familial Alzheimer's disease. Proc Natl Acad Sci USA 90:1977-1981